ProCE Banner Activity

Impact of Hydroxychloroquine on MACE in Medicare Recipients With Rheumatoid Arthritis

Slideset Download
Conference Coverage
Retrospective cohort suggests HCQ did not protect against MACE among patients initiating treatment within the prior year but did reduce risk of all-cause mortality.

Released: November 18, 2019

Expiration: November 16, 2020

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead

Mallinckrodt Pharmaceuticals